[Retracted] Radiosensitizing Effect of Celastrol by Inhibiting G2/M Phase Arrest Induced by the c-myc Gene of Human SW1353 Chondrosarcoma Cells: Network and Experimental Analyses

Table 3

Summary of celastrol information.

Drug name	Target	Symbol
Tripterine	NR3C1	Glucocorticoid receptor
	VEGFA	Vascular endothelial growth factor A
MOL003186	CCND1	G1/S-specific cyclin-D1
	BCL2	Apoptosis regulator Bcl-2
	BCL2L1	Bcl-2-like protein 1
	BAX	Apoptosis regulator BAX
	FLT1	Vascular endothelial growth factor receptor 1
	KDR	Vascular endothelial growth factor receptor 2
	MMP9	Matrix metalloproteinase-9
	JUN	Transcription factor AP-1
	PTGS2	Prostaglandin G/H synthase 2
	BIRC5	Baculoviral IAP repeat-containing protein 5
	BIRC2	Baculoviral IAP repeat-containing protein 2
	CFLAR	CASP8 and FADD-like apoptosis regulator
	AKR1B1	Aldose reductase
	CDC37	Hsp90 cochaperone Cdc37
	MMP2	72 kDa type IV collagenase
	TIMP1	Metalloproteinase inhibitor 1
	TIMP2	Metalloproteinase inhibitor 2
	MMP1	Interstitial collagenase
	MYC	Myc proto-oncogene protein
	FNDC3B	Fibronectin
	COL7A1	Collagen alpha-1 (VII) chain
	COL4A4	Transforming growth factor beta-1
	RELA	Collagen alpha-4 (IV) chain